Oaktree Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Oaktree Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-134,000	Closed	-$48.2K	–	301
2023 Q1	$48.2K	Hold	134,000	–	–	﹤0.01%	294
2022 Q4	$119K	Hold	134,000	–	–	﹤0.01%	340
2022 Q3	$210K	Hold	134,000	–	–	﹤0.01%	376
2022 Q2	$269K	Sell	134,000 -16,000	-11%	-$27.7K	﹤0.01%	355
2022 Q1	$349K	Hold	150,000	–	–	﹤0.01%	348
2021 Q4	$697K	Buy	150,000 +16,000	+12%	+$99.3K	0.01%	326
2021 Q3	$1.02M	Hold	134,000	–	–	0.02%	243
2021 Q2	$1.3M	Sell	134,000 -186,000	-58%	-$1.48M	0.02%	179
2021 Q1	$2.65M	Buy	+320,000	New	+$3.38M	0.04%	163
2020 Q3	–	Sell	-100,500	Closed	-$631K	–	197
2020 Q2	$631K	Buy	+100,500	New	+$385K	0.01%	178

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return